Cargando…

Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine – a pilot study

BACKGROUND: The AS04-adjuvanted bivalent L1 virus-like-particle (VLP) vaccine (Cervarix™) against infection with human papillomavirus (HPV) types 16/18 holds great promise to prevent HPV16/18 infections and associated neoplasias, but it is important to rule out significant co-factors of the neoplasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namujju, Proscovia B, Pajunen, Emma, Simen-Kapeu, Aline, Hedman, Lea, Merikukka, Marko, Surcel, Helja-Marja, Kirnbauer, Reinhard, Apter, Dan, Paavonen, Jorma, Hedman, Klaus, Lehtinen, Matti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105789/ https://www.ncbi.nlm.nih.gov/pubmed/25011477 http://dx.doi.org/10.1186/1756-0500-7-445

Ejemplares similares

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
por: Namujju, Proscovia B, et al.
Publicado: (2011)

Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries
por: Natunen, Kari, et al.
Publicado: (2011)

A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983–2003
por: Lyytikäinen, Erika, et al.
Publicado: (2008)

Cancer Registry follow‐up for 17 million person‐years of a nationwide maternity cohort
por: Lehtinen, Matti, et al.
Publicado: (2017)

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial
por: Lehtinen, Matti, et al.
Publicado: (2016)

Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
por: Gray, Penelope, et al.
Publicado: (2021)

Immunopathogenesis of Chlamydial Pelvic Inflammatory Disease: The Role of Heat-Shock Proteins
por: Paavonen, Jorma, et al.
Publicado: (1994)

Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012)

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland
por: Lehtinen, Matti, et al.
Publicado: (2021)

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Newly discovered KI, WU, and Merkel cell polyomaviruses: No evidence of mother-to-fetus transmission
por: Sadeghi, Mohammadreza, et al.
Publicado: (2010)

Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study
por: Schock, Helena, et al.
Publicado: (2016)

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12–15 years: end-of-study results from a community-randomized study up to 6.5 years
por: Bi, Dan, et al.
Publicado: (2019)

Maternal Smoking and the Risk of Cancer in Early Life – A Meta-Analysis
por: Rumrich, Isabell Katharina, et al.
Publicado: (2016)

Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial
por: Garland, Suzanne M., et al.
Publicado: (2016)

F134. MATERNAL PRENATAL C-REACTIVE PROTEIN AND ADOLESCENT NEURODEVELOPMENTAL OUTCOMES IN THE NORTHERN FINLAND BIRTH COHORT 1986
por: Ramsay, Hugh, et al.
Publicado: (2018)

Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial
por: Lehtinen, Matti, et al.
Publicado: (2019)

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials
por: Lehtinen, Matti, et al.
Publicado: (2017)

Papillomavirus-like Particles in Equine Medicine
por: Hainisch, Edmund K., et al.
Publicado: (2023)

Most women living with HIV can deliver vaginally—National data from Finland 1993–2013
por: Aho, Inka, et al.
Publicado: (2018)

O10.1. MATERNAL PRENATAL C-REACTIVE PROTEIN, NEURODEVELOPMENT AND OTHER RISK FACTORS FOR PSYCHOSIS IN ADOLESCENT OFFSPRING IN THE NORTHERN FINLAND BIRTH COHORT 1986
por: Ramsay, Hugh, et al.
Publicado: (2020)

Sexually Transmitted Infections and Risk of Epithelial Ovarian Cancer: Results From the Finnish Maternity Cohort
por: Skarga, Elizaveta, et al.
Publicado: (2023)

Should public health interventions aimed at reducing childhood overweight and obesity be gender-focused?
por: Simen-Kapeu, Aline, et al.
Publicado: (2010)

Maternal Enterovirus Infection as a Risk Factor for Type 1 Diabetes in the Exposed Offspring
por: Viskari, Hanna, et al.
Publicado: (2012)

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland
por: Korhonen, Suvi, et al.
Publicado: (2019)

The MATEX cohort – a Finnish population register birth cohort to study health effects of prenatal exposures
por: Rumrich, Isabell K., et al.
Publicado: (2017)

Missed hepatitis b/c or syphilis diagnosis among Kurdish, Russian, and Somali origin migrants in Finland: linking a population-based survey to the national infectious disease register
por: Tiittala, Paula, et al.
Publicado: (2018)

Associations Between Maternal Prenatal C-Reactive Protein and Risk Factors for Psychosis in Adolescent Offspring: Findings From the Northern Finland Birth Cohort 1986
por: Ramsay, Hugh, et al.
Publicado: (2020)

Interruption of CXCL13-CXCR5 Axis Increases Upper Genital Tract Pathology and Activation of NKT Cells following Chlamydial Genital Infection
por: Jiang, Janina, et al.
Publicado: (2012)

Correction: Interruption of CXCL13-CXCR5 Axis Increases Upper Genital Tract Pathology and Activation of NKT Cells following Chlamydial Genital Infection
por: Jiang, Janina, et al.
Publicado: (2013)

Do improvements in outreach, clinical, and family and community-based services predict improvements in child survival? An analysis of serial cross-sectional national surveys
por: Binkin, Nancy, et al.
Publicado: (2011)

Galvanizing Action on Primary Health Care: Analyzing Bottlenecks and Strategies to Strengthen Community Health Systems in West and Central Africa
por: Simen-Kapeu, Aline, et al.
Publicado: (2021)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

Moral dilemma(s) in human papillomavirus vaccination – revisiting the role of the herd effect
por: Lehtinen, Matti, et al.
Publicado: (2021)

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
por: Szarewski, Anne, et al.
Publicado: (2013)

Clinical Assessment and Improved Diagnosis of Bocavirus-induced Wheezing in Children, Finland
por: Söderlund-Venermo, Maria, et al.
Publicado: (2009)

Cardiac remodelling in association with left ventricular dyssynchrony and systolic dysfunction in patients with coronary artery disease
por: Hämäläinen, Hanna, et al.
Publicado: (2022)

Detection of Human Papillomavirus DNA by AffiProbe HPV-DNA Test Kit in Cervical Scrapes or Biopsies-Histopathologic Correlates
por: Nieminen, Pekka, et al.
Publicado: (1994)

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
por: Huber, Bettina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2afbr0tgai7v1f018p8ojbq5ne